Internet-delivered CBT for Paediatric OCD
Primary Purpose
Obsessive-Compulsive Disorder
Status
Active
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Internet-delivered cognitive behavioral therapy (ICBT)
Cognitive behavioral therapy (CBT)
Sponsored by
About this trial
This is an interventional treatment trial for Obsessive-Compulsive Disorder
Eligibility Criteria
Inclusion Criteria:
- Primary DSM-5 diagnosis of OCD
- Total score of ≥16 on the Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS)
- Age between 7 and 17 years
- Ability to read and write Swedish and with access to a computer and use of internet.
- Participants on psychotropic medication must had been on a stable dose for the last 6 weeks prior to baseline assessment. If the child is on medication for OCD, they will be requested to stay on stable doses for the duration of the trial.
Exclusion Criteria:
- Organic brain disorders, global learning disabilities, autism spectrum disorder, psychosis, bipolar disorder and severe eating disorder.
- Suicidal ideation
- Not able to understand the basics of the ICBT self-help material, patient being housebound or in need of intensive- or in-patient treatment.
- Having completed a course of CBT for OCD within the last 12 months (defined as at least 5 sessions CBT including exposure and response prevention).
- Children with ongoing psychological treatment for OCD or another anxiety disorder will not be included in the study.
Sites / Locations
- BUP Specialmottagning
- Child and Adolescent Psychiatry (CAP) research center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Stepped care
Gold standard treatment
Arm Description
Internet-delivered cognitive behavioral therapy (ICBT)
Cognitive behavioral therapy (CBT)
Outcomes
Primary Outcome Measures
Children's Yale Brown Obsessive-Compulsive Scale (CY-BOCS)
Change in OCD symptom severity from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1, 2 and 5 years follow-up. Primary endpoint is 6 months follow-up.
Secondary Outcome Measures
Clinical global impression severity (CGI-S)
Change in global severity from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1, 2 and 5 years follow-up.
Clinical global impression improvement (CGI-I)
Change in global improvement from week 16 to 3 and 6 months after treatment has ended, and at 1, 2 and 5 years follow-up.
Children's global assessment scale (C-GAS)
Change in global functioning from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1 year follow-up.
Obsessive-compulsive inventory - child version (OCI-CV)
Change in child-rated OCD symptoms from baseline to week 16 and 3 and 6 months after treatment has ended, at 1 year follow-up, and weekly during treatment.
The Child Health Utility 9D (CHU9D)
Change in general health from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1 year follow-up.
Insomnia Severity Index (ISI)
Change in sleep problems from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1 year follow-up
Children's Obsessional Compulsive Inventory Revised - parent version (ChOCI-R)
Change in parent-rated OCD symptoms from baseline to week 16 and 3 and 6 months after treatment has ended, at 1 year follow-up, and weekly during treatment.
Family accommodation scale for obsessive-compulsive disorder - self-rated version (FAS-SR)
Change in parent-rated family accommodation from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1 year follow-up
Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P)
Change in economic costs from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1, 2 and 5 years follow-up.
Mood and Feeling Questionnaire (MFQ)
Change in child and parent rated depressive symptoms from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1 year follow-up
Education, work and social adjustment scale (EWSAS)
Change in child and parent rated impairment and functioning from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1 year follow-up
Full Information
NCT ID
NCT03263546
First Posted
August 18, 2017
Last Updated
March 10, 2023
Sponsor
Karolinska Institutet
Collaborators
Region Stockholm, Vastra Gotaland Region
1. Study Identification
Unique Protocol Identification Number
NCT03263546
Brief Title
Internet-delivered CBT for Paediatric OCD
Official Title
Implementation of Internet-delivered Cognitive-behavior Therapy for Paediatric Obsessive-compulsive Disorder in the Clinic: a Randomized Stepped Care Non-inferiority Trial
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
October 6, 2017 (Actual)
Primary Completion Date
April 28, 2020 (Actual)
Study Completion Date
December 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet
Collaborators
Region Stockholm, Vastra Gotaland Region
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The purpose of this study is to investigate if therapist-guided internet-delivered cognitive behavioral therapy (ICBT) in a stepped-care approach is an effective and cost-effective treatment in reducing OCD symptoms for children and adolescents compared to gold standard treatment (face-to-face CBT).
Detailed Description
A randomized controlled non-inferiority trial comparing therapist-guided internet-delivered cognitive behavioral therapy (ICBT) in a stepped care model with face-to-face CBT for children and adolescents with obsessive-compulsive disorder (OCD).
Participants will be randomized to either stepped care ICBT or to gold standard face-to-face CBT. One group (stepped care) will be first offered ICBT for 16 weeks. Non-responders at the 3-month follow-up will receive additional face-to-face CBT. The other group (gold standard treatment) will be randomized directly to receive face-to-face CBT for 16 weeks. Non-responders will, as in the other group, receive additional face-to-face treatment after the 3-month follow-up. The primary endpoint will be at 6-month follow-up. Long-term effects are also investigated (1 year, 2 years and 5 years after treatment completion).
The primary objective is to evaluate whether ICBT in a stepped care approach will be non-inferior to gold standard treatment (face-to-face CBT) in reducing OCD symptoms, depression, impairment, sleep problems, health and functioning. The secondary objective is to a) carry out a full health economic evaluation and b) investigate if self-referred and referred participants differ regarding outcome in the two treatment groups.
The hypotheses are:
An ICBT stepped care approach will be non-inferior to gold standard treatment (face-to-face CBT) in reducing OCD symptoms.
The stepped care approach will be associated with lower costs, such as reduced therapist and administration times, service utilization, minimized work and school absence for families etc., compared to gold standard treatment.
Self-referred patients will benefit significantly better than referred patients regarding outcome in the ICBT group, but there will not be any difference in the face-to-face CBT group.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obsessive-Compulsive Disorder
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
152 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Stepped care
Arm Type
Experimental
Arm Description
Internet-delivered cognitive behavioral therapy (ICBT)
Arm Title
Gold standard treatment
Arm Type
Active Comparator
Arm Description
Cognitive behavioral therapy (CBT)
Intervention Type
Behavioral
Intervention Name(s)
Internet-delivered cognitive behavioral therapy (ICBT)
Intervention Description
Participants will receive internet-delivered CBT with therapist support for 16 weeks. The treatment consists of 14 online chapters with interactive features as videos and illustrations. The treatment has the main focus on exposure with ritual prevention. The children and parents have regular contact with a personal assigned therapist via written text messages in the platform.
Participants that are classified as non-responders at 3 months follow-up will receive face-to-face CBT of up to 12 sessions over 12 weeks.
Intervention Type
Behavioral
Intervention Name(s)
Cognitive behavioral therapy (CBT)
Intervention Description
Participants in the gold standard group will receive 14 individual face-to-face CBT sessions over 16 weeks. The treatment is based on current evidence based recommendations for OCD, and focuses on exposure with ritual prevention.
Participants that are classified as non-responders at 3 months follow-up will receive additional face-to-face CBT of up to 12 sessions over 12 weeks.
Primary Outcome Measure Information:
Title
Children's Yale Brown Obsessive-Compulsive Scale (CY-BOCS)
Description
Change in OCD symptom severity from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1, 2 and 5 years follow-up. Primary endpoint is 6 months follow-up.
Time Frame
week 0, week 16, at 3 and 6 months follow-up, at 1, 2 and 5 years follow-up.
Secondary Outcome Measure Information:
Title
Clinical global impression severity (CGI-S)
Description
Change in global severity from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1, 2 and 5 years follow-up.
Time Frame
week 0, week 16, at 3 and 6 months follow-up, at 1, 2 and 5 years follow-up
Title
Clinical global impression improvement (CGI-I)
Description
Change in global improvement from week 16 to 3 and 6 months after treatment has ended, and at 1, 2 and 5 years follow-up.
Time Frame
week 16, at 3 and 6 months follow-up, at 1, 2 and 5 years follow-up
Title
Children's global assessment scale (C-GAS)
Description
Change in global functioning from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1 year follow-up.
Time Frame
week 0, week 16, at 3 and 6 months follow-up, at 1 year follow-up
Title
Obsessive-compulsive inventory - child version (OCI-CV)
Description
Change in child-rated OCD symptoms from baseline to week 16 and 3 and 6 months after treatment has ended, at 1 year follow-up, and weekly during treatment.
Time Frame
week 0, week 16, at 3 and 6 months follow-up, at 1 year follow-up, and weekly during treatment
Title
The Child Health Utility 9D (CHU9D)
Description
Change in general health from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1 year follow-up.
Time Frame
week 0, week 16, at 3 and 6 months follow-up, at 1 year follow-up
Title
Insomnia Severity Index (ISI)
Description
Change in sleep problems from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1 year follow-up
Time Frame
week 0, week 16, at 3 and 6 months follow-up, at 1 year follow-up
Title
Children's Obsessional Compulsive Inventory Revised - parent version (ChOCI-R)
Description
Change in parent-rated OCD symptoms from baseline to week 16 and 3 and 6 months after treatment has ended, at 1 year follow-up, and weekly during treatment.
Time Frame
week 0, week 16, at 3 and 6 months follow-up, at 1 year follow-up, and weekly during treatment
Title
Family accommodation scale for obsessive-compulsive disorder - self-rated version (FAS-SR)
Description
Change in parent-rated family accommodation from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1 year follow-up
Time Frame
week 0, week 16, at 3 and 6 months follow-up, at 1 year follow-up
Title
Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P)
Description
Change in economic costs from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1, 2 and 5 years follow-up.
Time Frame
week 0, week 16, at 3 and 6 months follow-up, at 1, 2 and 5 years follow-up.
Title
Mood and Feeling Questionnaire (MFQ)
Description
Change in child and parent rated depressive symptoms from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1 year follow-up
Time Frame
week 0, week 16, at 3 and 6 months follow-up, at 1 year follow-up
Title
Education, work and social adjustment scale (EWSAS)
Description
Change in child and parent rated impairment and functioning from baseline to week 16 and 3 and 6 months after treatment has ended, and at 1 year follow-up
Time Frame
week 0, week 16, at 3 and 6 months follow-up, at 1 year follow-up
Other Pre-specified Outcome Measures:
Title
Autism Spectrum Quotient (AQ-10)
Description
Measure of autistic symptoms at baseline
Time Frame
week 0
Title
Treatment credibility and expectancy scale
Description
Child and parent version. Investigate if both conditions have equal credibility in order to rule out placebo.
Time Frame
week 2
Title
Working alliance inventory (WAI)
Description
Child and parent version. Investigate if both conditions have equal working alliance in order to rule out non-specific factors.
Time Frame
week 2
Title
Client Satisfaction Questionnaire (CSQ-8)
Description
Child and parent version. Investigate if both conditions have equal satisfaction.
Time Frame
week 16 and at 6 months follow-up
Title
Patient EX/RP Adherence Scale (PEAS)
Description
Clinician-rated version during face-to-face CBT. Self-rated version during both ICBT and face-to-face CBT. Investigate treatment adherence in both conditions.
Time Frame
week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8, week 9, week 10, week 11, week 12, week 13, week 14, week 15, week 16
Title
internet intervention Patient Adherence Scale (iiPAS)
Description
Investigate treatment adherence in the ICBT condition.
Time Frame
week 8 and 16
Title
Parental strategy scale
Description
Investigate the use of parental strategies weekly during treatment.
Time Frame
week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8, week 9, week 10, week 11, week 12, week 13, week 14, week 15, week 16
10. Eligibility
Sex
All
Minimum Age & Unit of Time
7 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Primary DSM-5 diagnosis of OCD
Total score of ≥16 on the Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS)
Age between 7 and 17 years
Ability to read and write Swedish and with access to a computer and use of internet.
Participants on psychotropic medication must had been on a stable dose for the last 6 weeks prior to baseline assessment. If the child is on medication for OCD, they will be requested to stay on stable doses for the duration of the trial.
Exclusion Criteria:
Organic brain disorders, global learning disabilities, autism spectrum disorder, psychosis, bipolar disorder and severe eating disorder.
Suicidal ideation
Not able to understand the basics of the ICBT self-help material, patient being housebound or in need of intensive- or in-patient treatment.
Having completed a course of CBT for OCD within the last 12 months (defined as at least 5 sessions CBT including exposure and response prevention).
Children with ongoing psychological treatment for OCD or another anxiety disorder will not be included in the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eva Serlachius, MD, PhD
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
BUP Specialmottagning
City
Göteborg
Country
Sweden
Facility Name
Child and Adolescent Psychiatry (CAP) research center
City
Stockholm
ZIP/Postal Code
11330
Country
Sweden
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
33974020
Citation
Aspvall K, Andersson E, Melin K, Norlin L, Eriksson V, Vigerland S, Jolstedt M, Silverberg-Morse M, Wallin L, Sampaio F, Feldman I, Bottai M, Lenhard F, Mataix-Cols D, Serlachius E. Effect of an Internet-Delivered Stepped-Care Program vs In-Person Cognitive Behavioral Therapy on Obsessive-Compulsive Disorder Symptoms in Children and Adolescents: A Randomized Clinical Trial. JAMA. 2021 May 11;325(18):1863-1873. doi: 10.1001/jama.2021.3839.
Results Reference
derived
PubMed Identifier
31642928
Citation
Aspvall K, Andersson E, Lenhard F, Melin K, Norlin L, Wallin L, Silverberg-Morse M, Feldman I, Bottai M, Mataix-Cols D, Serlachius E. Stepped Care Internet-Delivered vs Face-to-Face Cognitive-Behavior Therapy for Pediatric Obsessive-Compulsive Disorder: A Trial Protocol for a Randomized Noninferiority Trial. JAMA Netw Open. 2019 Oct 2;2(10):e1913810. doi: 10.1001/jamanetworkopen.2019.13810.
Results Reference
derived
Learn more about this trial
Internet-delivered CBT for Paediatric OCD
We'll reach out to this number within 24 hrs